|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
EP3092049A1
(en)
|
2014-01-08 |
2016-11-16 |
Flodesign Sonics Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
CA2948462A1
(en)
|
2014-05-15 |
2015-11-19 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
EP3184548A1
(en)
*
|
2015-12-23 |
2017-06-28 |
Miltenyi Biotec GmbH |
Chimeric antigen receptor with cytokine receptor activating or blocking domain
|
|
WO2017181119A2
(en)
*
|
2016-04-15 |
2017-10-19 |
Novartis Ag |
Compositions and methods for selective protein expression
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
WO2018169948A1
(en)
|
2017-03-13 |
2018-09-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
CN117363636A
(zh)
|
2017-03-27 |
2024-01-09 |
新加坡国立大学 |
一种编码嵌合受体的多核苷酸
|
|
JOP20180027A1
(ar)
*
|
2017-03-28 |
2019-01-30 |
Cell Design Labs Inc |
بوليبيبتيدات مخلطة و طرق لتغيير موضع الغشاء فيها
|
|
US20230192839A1
(en)
*
|
2017-04-12 |
2023-06-22 |
Pfizer Inc. |
Antibodies having conditional affinity and methods of use thereof
|
|
JP7555090B2
(ja)
*
|
2017-05-19 |
2024-09-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
細胞療法を調節するための分子スイッチとしての抗体化学誘導二量体形成化合物（ＡｂＣＩＤ）
|
|
US20230159611A1
(en)
*
|
2017-07-03 |
2023-05-25 |
Yale University |
Small molecule adapter regulated, target specific chimeric antigen receptor bearing t cells (smart cars)
|
|
CN107312797B
(zh)
*
|
2017-07-28 |
2021-06-18 |
广州中科蓝华生物科技有限公司 |
一种蛋白调控系统及其制备方法和应用
|
|
JP7654240B2
(ja)
|
2017-09-19 |
2025-04-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
キメラ抗原受容体ｔ細胞治療のための組成物およびその使用
|
|
US11999802B2
(en)
|
2017-10-18 |
2024-06-04 |
Novartis Ag |
Compositions and methods for selective protein degradation
|
|
MA51158A
(fr)
*
|
2017-12-14 |
2020-10-21 |
Bluebird Bio Inc |
Récepteurs daric nkg2d
|
|
AU2018385699B2
(en)
*
|
2017-12-14 |
2024-08-15 |
Regeneron Pharmaceuticals, Inc. |
Daric interleukin receptors
|
|
BR112020009889A2
(pt)
|
2017-12-14 |
2020-11-03 |
Flodesign Sonics, Inc. |
acionador e controlador de transdutor acústico
|
|
EP3502130A1
(en)
|
2017-12-20 |
2019-06-26 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
WO2019122188A1
(en)
|
2017-12-20 |
2019-06-27 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
CN111801348A
(zh)
|
2018-02-09 |
2020-10-20 |
新加坡国立大学 |
活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
|
|
WO2019154313A1
(zh)
|
2018-02-11 |
2019-08-15 |
江苏恒瑞医药股份有限公司 |
一种分离的嵌合抗原受体以及包含其的修饰t细胞及用途
|
|
US12441787B2
(en)
|
2018-04-02 |
2025-10-14 |
National University Of Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
CA3098014A1
(en)
*
|
2018-04-27 |
2019-10-31 |
Crispr Therapeutics Ag |
Anti-bcma car-t-cells for plasma cell depletion
|
|
GB201813178D0
(en)
*
|
2018-08-13 |
2018-09-26 |
Autolus Ltd |
Cell
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
MX2021003435A
(es)
|
2018-09-28 |
2021-06-15 |
Massachusetts Inst Technology |
Moleculas inmunomoduladoras localizadas en el colageno y metodos de las mismas.
|
|
US20220267435A1
(en)
*
|
2018-10-03 |
2022-08-25 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
US20210386781A1
(en)
|
2018-10-05 |
2021-12-16 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
EP3632461A1
(en)
|
2018-10-05 |
2020-04-08 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
KR20210124238A
(ko)
*
|
2019-01-04 |
2021-10-14 |
더 유니버서티 오브 시카고 |
Ｒｎａ 조절을 위한 시스템 및 방법
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
EP3966242A1
(en)
|
2019-05-04 |
2022-03-16 |
Inhibrx, Inc. |
Cd123-binding polypeptides and uses thereof
|
|
BR112021020999A2
(pt)
|
2019-05-04 |
2021-12-14 |
Inhibrx Inc |
Polipeptídeos de ligação à clec12a e usos dos mesmos
|
|
MX2021013416A
(es)
|
2019-05-04 |
2021-12-10 |
Inhibrx Inc |
Polipeptidos de union al antigeno cd33 y sus usos.
|
|
SG11202111890RA
(en)
*
|
2019-05-08 |
2021-11-29 |
Inhibrx Inc |
Cd33 targeted immunotherapies
|
|
AU2020267559A1
(en)
*
|
2019-05-08 |
2022-01-06 |
2Seventy Bio, Inc. |
CD123 targeted immunotherapies
|
|
CA3148027A1
(en)
*
|
2019-05-08 |
2020-11-12 |
2Seventy Bio, Inc. |
Cll-1 targeted immunotherapies
|
|
EP3990491A1
(en)
|
2019-06-26 |
2022-05-04 |
Massachusetts Institute of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
WO2021087183A1
(en)
*
|
2019-10-31 |
2021-05-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric antigen receptor targeting cancer cells
|
|
EP4073111A1
(en)
*
|
2019-12-11 |
2022-10-19 |
Cilag GmbH International |
Multispecific binding molecules comprising ltbr and edb binding domains and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
EP4168438A4
(en)
*
|
2020-06-22 |
2024-07-10 |
Ramot at Tel-Aviv University Ltd. |
Multi subunit protein modules, cells expressing same and uses thereof
|
|
AU2022227686A1
(en)
|
2021-02-25 |
2023-07-27 |
Lyell Immunopharma, Inc. |
Ror1 targeting chimeric antigen receptor
|
|
WO2023081715A1
(en)
|
2021-11-03 |
2023-05-11 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
TW202421651A
(zh)
*
|
2022-09-20 |
2024-06-01 |
美商達納法伯癌症協會 |
用於靶向降解及治療劑之遞送之受體介導之胞吞作用
|
|
CN119638840A
(zh)
*
|
2023-09-15 |
2025-03-18 |
东莞市朋志生物科技有限公司 |
一种抗糖类抗原153的抗体及其应用
|